Antioxidant state and mortality from coronary heart disease in Lithuanian and Swedish men: Concomitant cross sectional study of men aged 50

British Medical Journal

Volumn 314, Issue 7081, 1997, Pages 629-633

  Kristenson, Margareta ^a   Ziedén, Bo ^b   Kucinskienë, Zita ^a   Elinder, Liselotte Schäfer ^c   Bergdahl, Björn ^d   Ehving, Birgitta ^a   Abaravicius, Ajgis ^a   Razinkovienë, Laima ^b   Calkauskas, Henrikas ^a   Olsson, Anders G ^c  

^a LINKÖPING UNIVERSITY   (Sweden)

^b Steadman Philippon Research Institute   (United States)

^c VILNIUS UNIVERSITY   (Lithuania)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VITAMIN;

ADULT; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; HUMAN; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; LIPID OXIDATION; LIPOPROTEIN BLOOD LEVEL; LITHUANIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK FACTOR; SMOKING; SMOKING HABIT; SWEDEN; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN BLOOD LEVEL;

ANTIOXIDANTS; BLOOD PRESSURE; BODY WEIGHT; CHOLESTEROL; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; HUMANS; LITHUANIA; MALE; MIDDLE AGED; RISK FACTORS; SWEDEN; TRIGLYCERIDES; VITAMINS;

EID: 8044223400     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Feachem R. Health decline in Eastern Europe. Nature 1994;367:313-4.
2. Uemura K, Zbynek P. Trends in cardiovascular disease mortality in industrialised countries since 1950. Wrldllealth Stat Q 1988;41:155-78.
3. Unicef. Crises in mortality, health and nutrition, Florence: Unicef, 1994.
4. Bobak M, Marmot M. East-West mortality divide and its potential explanations: proposed research agenda. BMJ 1996;312:421-5.
5. Bosma H, Appels A, Sturmans F, Grabauskas V, Gostautas A, Differences in mortality and coronary heart disease between Lithuania and the Netherlands: results from the WHO Kaunas-Rotterdam intervention study (KRIS). Int J Epidcrniol 1991;23:12-8.
6. Witztum JL, Steinberg D. Role of oxidised low density lipoprotcin in atherogenesis. y Clin Invest 1991;88:1785-92.
7. Regnström J, Nilsson J, Tornvall P, Landou C, Hamstcn A. Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man. Lancet 1992;339:1183-6.
8. Andrews B, Burnand K, Paganga G, Browse B, Rice-Evans C, Sommerville K, et al. Oxidisability of low density lipoproteins in patients with carotid or femoral artery atherosclerosis. Atherosclerosis 1995;112:77-84.
9. Cominacini L, Garbin U, Pastorino AM. Predisposition to LDL oxidaüon in patients with and without angiographically established coronary artery disease. Atherosclerosis 1993;99:G3.
10. Kardinaal AFM, Kok FJ, Ringstad J, Gomez-Aracena J, Mazaev VP, Kolumeier L, et al. Anüoxidants in adipose tissue and risk of myocardial infarction: the EURAMIC study. Lancet 1993;342:1379-84.
11. World Health Organisation. Measuring obesity-classification and description of anthropométrie data. Report on a WHO consultation on die epidemiology of obesity. Copenhagen: WHO, 1989.
12. Williamson DF, Kahn HS, Worthman CM, Burnette JC, Russell CM. Precision of recumbent andiropometry. Am J Hum Biol 1993; 15:159-7.
13. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972)18:499-502.
14. Mölgaard J, von Schencfc H, Olsson AG. Effects of simvastatin on plasma lipid, lipoprotein and apolipoprotein concentrations in hypcrcholesteroleemia. Eur Heart J 1988;9:541-51.
15. Kleinveld HA, Hak-Lemmers HL, Stalenhoef AFII, Demacker PNM. Improved measurement of low-density-lipoprotein susceptibility to copper-induced oxidation: application of a short procedure for isolating low-density lipoprotein. Clin Chem 1992;38:2066-72.
16. Schäfer Elinder L, Walldius G. Simultaneous measurement of serum probucol and lipid-soluble antioxidants. J Lipid 1992;33:131-7.
17. Bingham SA, Nelson M, Paul AA, Haraldsdottir J, Bjorge Lnken E, van Staveren WA. Metliods for data collection at an individual level. In: Cameron ME, van Staveren WA, cd. Manual on methodology for food consumption studies. Vol 57. Oxford: Oxford University Press, 1987:53-106.
18. National Food Administration. Food composition table-energy and nutrients. Stockholm: Livsmedelsvcrket, 1993.
19. Skurihin IM, Volgariov MX, Food chemical composition. Moscow: Agropromtzdat, 1987.
20. Logan RL, Riemersma RA, Thomson M, Oli cr MF, Olsson AC, Walldius G, et al. Risk factors for ischaemic heart-disease in normal men aged 40. Lancet 1978;i:949-55.
21. Olsson AG, Holmquist L, Walldius G, Hâdell K, Carlson LA, Riccardi G, et al. Serum apolipoproteins, lipoproleins and fatty acids in relation to ischaemic heart disease in Normern and Southern European males. Acta Med Scand 1988:223:3-13.
22. Evans A, Ruidavets J-B, McCrum E, Cambou J-P, McClcan R, Douste-Blazy B, et al. Autres pays, autres coeurs? Dietary patterns, risk factors and ischaemic heart disease in Belfast and Toulouse. QJ Med 1995;88:469-77.
23. Pajak A, Kuulasmaa K, Tuomilebto J, Ruokokoski E. Geographical variation in the major risk factors of coronary heart disease in men and women aged 35-64 years. The WHO MONICA project, World Health Stat Q 1988;41:115-39.
24. Ohrvall M, Sundlof G, Vessby B, Gamma, but not alpha, tocopherol levels in serum are reduced in coronary heart disease patients. J Intern Med 1996;239:111-7.
25. Riemersma RA, Wood DA, Macintyre CCA, EIton RA, Gey KF, Oliver MF. Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene. Lancet 1991:337:1-5.
26. Rimm EB, Stampfer MJ, Asclicrio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993:328:1450-6.
27. Stephens N, Parsons A, Schofield P, Kelly F, Cheeseman K, Mitchinson MJ, et ai Randomised controlled trial of vitamin E in patients widi coronary disease: Cambridge heart oxidation study (CHAOS). Lancet 1996;347:781-6.
28. Street DA, Comstock GW, Salkeld RM, Schuep W, Klag MJ. Serum antioxidants and myocardial infarction. Are low levels of carotenoids and α-tocopherol risk factors for myocardial infarction? Circulation 1994;90:1154-61.
29. Gey KF, Stahelin HB, Eichholzer M. Poor plasma status of carotene and vitamin C is associated with higher mortality from ischémie heart disease and stroke: Basel Prospective Study. Clin Imnt 1993;71:3-6.
30. Hennekens C, Buring J, Manson J, Stampfer M, Rosner B, Cook NR, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996;334:1145-9.
31. Omenn G, Goodman G, Thornquist M, Balmes J, Cullen MR, Glass A, et al. Effects of combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996;334:1150-5.
32. Mensink R, Katan M. Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials. Atherosclerosis and Tltromtosis 1992;12:911-9.
33. Kardinaal AFM, Aro A, Kark JD, Riemersma RA, van't Veer P, Gomez-Aracena J, et al. Association between -carotene and acute myocardial infarction depends on polyunsaturated fatty acid status. Atherosclerosis, Thrombosis and Vascular Biology 1995;15:726-32.